nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cross-reactive pH-dependent EGFR antibody with improved tumor selectivity and penetration obtained by structure-guided engineering
|
Liu, Ximing |
|
|
27 |
C |
p. 256-269 |
artikel |
2 |
Adding recombinant AAVs to the cancer therapeutics mix
|
Mulcrone, Patrick L. |
|
|
27 |
C |
p. 73-88 |
artikel |
3 |
An oncolytic virus as a promising candidate for the treatment of radioresistant oral squamous cell carcinoma
|
Gohara, Shunsuke |
|
|
27 |
C |
p. 141-156 |
artikel |
4 |
Azelnidipine inhibits esophageal squamous cell carcinoma proliferation in vivo and in vitro by targeting MEK1/2
|
Zhao, Lili |
|
|
27 |
C |
p. 61-72 |
artikel |
5 |
Azelnidipine may be a valuable drug for chemoprevention of ESCC with high MEK1/2 levels
|
Qian, Haili |
|
|
27 |
C |
p. 203 |
artikel |
6 |
Cancer stem/progenitor signatures refine the classification of clear cell renal cell carcinoma with stratified prognosis and decreased immunotherapy efficacy
|
Zhou, Peng |
|
|
27 |
C |
p. 167-181 |
artikel |
7 |
Cross-study safety analysis of risk factors in CAR T cell clinical trials: An FDA database pilot project
|
Foster, Matthew |
|
|
27 |
C |
p. 182-194 |
artikel |
8 |
Development and comparison of 68Ga/18F/64Cu-labeled nanobody tracers probing Claudin18.2
|
Wei, Weijun |
|
|
27 |
C |
p. 305-314 |
artikel |
9 |
DNA-damaging cancer cells to improve virotherapy
|
Garcia-Moure, Marc |
|
|
27 |
C |
p. 124-125 |
artikel |
10 |
Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma
|
Spellerberg, Rebekka |
|
|
27 |
C |
p. 272-287 |
artikel |
11 |
Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
|
Shinohara, Haruka |
|
|
27 |
C |
p. 14-25 |
artikel |
12 |
Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3
|
Liu, Huitao |
|
|
27 |
C |
p. 89-99 |
artikel |
13 |
Enhanced tumor targeting and timely viral release of mesenchymal stem cells/oncolytic virus complex due to GRP78 and inducible E1B55K expressions greatly increase the antitumor effect of systemic treatment
|
Choi, Soojin |
|
|
27 |
C |
p. 26-47 |
artikel |
14 |
Exploring the potential of eRNAs in cancer immunotherapy
|
Luo, Lianxiang |
|
|
27 |
C |
p. 197-199 |
artikel |
15 |
Ferroptosis gene signature in cholangiocarcinoma
|
Cingaram, Pradeep Reddy |
|
|
27 |
C |
p. 195-196 |
artikel |
16 |
Gene-edited and CAR-NK cells: Opportunities and challenges with engineering of NK cells for immunotherapy
|
Wu, Xinyu |
|
|
27 |
C |
p. 224-238 |
artikel |
17 |
HKI-272 contributes to gemcitabine-mediated anti-proliferative and anti-metastatic effects through EGFR suppression in gallbladder cancer
|
Yang, Xuli |
|
|
27 |
C |
p. 126-140 |
artikel |
18 |
HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen
|
Mock, Jee-Young |
|
|
27 |
C |
p. 157-166 |
artikel |
19 |
Non-coding RNAs and glioma: Focus on cancer stem cells
|
Rajabi, Ali |
|
|
27 |
C |
p. 100-123 |
artikel |
20 |
Novel insights into circular RNA regulation in arsenic-exposure-induced lung cancer
|
Ao, Xiang |
|
|
27 |
C |
p. 200-202 |
artikel |
21 |
Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer
|
Behrens, Marshall D. |
|
|
27 |
C |
p. 239-255 |
artikel |
22 |
Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer
|
Araki, Hiroyuki |
|
|
27 |
C |
p. 3-13 |
artikel |
23 |
PROTACs in gastrointestinal cancers
|
Chen, Yu |
|
|
27 |
C |
p. 204-223 |
artikel |
24 |
Reinvigoration of innate and adaptive immunity via therapeutic cellular vaccine for patients with AML
|
Fujii, Shin-ichiro |
|
|
27 |
C |
p. 315-332 |
artikel |
25 |
ScRNA-seq and bulk RNA-seq reveal the characteristics of ferroptosis and establish a risk signature in cholangiocarcinoma
|
Yao, Wenchao |
|
|
27 |
C |
p. 48-60 |
artikel |
26 |
Thank you to our 2022 reviewers
|
|
|
|
27 |
C |
p. 270-271 |
artikel |
27 |
The IAP antagonist birinapant enhances chimeric antigen receptor T cell therapy for glioblastoma by overcoming antigen heterogeneity
|
Song, Edward Z. |
|
|
27 |
C |
p. 288-304 |
artikel |
28 |
The tRNA-derived fragment signature in lung cancer
|
Cingaram, Pradeep Reddy |
|
|
27 |
C |
p. 1-2 |
artikel |